Frontiers in Oncology | Molecular and Cellular Oncology

Correction

Accepted on 09 Apr 2025

Corrigendum: Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC

in Molecular and Cellular Oncology

Julia Meidenbauer
Matthias Wachter
Sebastian R Schulz
Nada Mostafa
Lilli Zülch
Benjamin Frey
Rainer Fietkau
Udo S Gaipl
Tina Jost

Frontiers in Oncology

doi 10.3389/fonc.2025.1607882

Review

Accepted on 09 Apr 2025

MYCN as an oncogene in pediatric brain tumors

in Molecular and Cellular Oncology

Adriana Fernandez Garcia
Jayden Jackson
Poorvi Iyer
Elissa Grace Oliver
Kosuke Funato

Frontiers in Oncology

doi 10.3389/fonc.2025.1584978

Review

Published on 09 Apr 2025

Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications

in Molecular and Cellular Oncology

Francisco Alejandro Lagunas-Rangel

Frontiers in Oncology

doi 10.3389/fonc.2025.1579054

Editorial

Published on 08 Apr 2025

Editorial: Deciphering the role of signature genes in cancer prognosis and therapy resistance

in Molecular and Cellular Oncology

Dalila L. Zanette
Manoj K. Pandey
Jawed A. Siddiqui

Frontiers in Oncology

doi 10.3389/fonc.2025.1591256

Correction

Published on 08 Apr 2025

Corrigendum: Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets

in Molecular and Cellular Oncology

Tomasz Sirek
Katarzyna Król-Jatręga
Przemysław Borawski
Nikola Zmarzły
Dariusz Boroń
Piotr Ossowski
Olga Nowotny-Czupryna
Kacper Boroń
Dominika Janiszewska-Bil
Elżbieta Mitka-Krysiak

Frontiers in Oncology

doi 10.3389/fonc.2025.1558771

Review

Published on 07 Apr 2025

Circulating tumor cell markers for early detection and drug resistance assessment through liquid biopsy

in Molecular and Cellular Oncology

Priya Yadav
Saravanan Rajendrasozhan
Ramzi Hadj Lajimi
Raja Ramadevi Patel
Dominique Heymann
N. Rajendra Prasad

Frontiers in Oncology

doi 10.3389/fonc.2025.1494723

178 views

Review

Published on 03 Apr 2025

Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications

in Molecular and Cellular Oncology

Shuzhen Mao
Junyan Li
Jiahui Huang
Lili Lv
Qilian Zhang
Qing Cheng
Xiaojing Liu
Zhiwei Bi
Jing Yao

Frontiers in Oncology

doi 10.3389/fonc.2025.1524763

339 views

Original Research

Published on 03 Apr 2025

Aryl hydrocarbon receptor-regulated long non-coding RNAs: implications for glycolipid metabolism and prognosis in hepatocellular carcinoma

in Molecular and Cellular Oncology

Xiaoli Xiao
Yao Liu
Xiaoyong Qu
Logen Liu
Guo-Qing Li
Honghui Chen
Linlin Zhou
Yanping Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1537481

210 views

Original Research

Published on 02 Apr 2025

Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting

in Molecular and Cellular Oncology

Sanjib Saha
Ulf-Göran Gerdtham
Gottfrid Sjödahl
Christel Häggström
James W. F. Catto
John D. Kelly
Anders Ullén
Lars Holmberg
Fredrik Liedberg

Frontiers in Oncology

doi 10.3389/fonc.2025.1556881

165 views

Review

Published on 02 Apr 2025

Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers

in Molecular and Cellular Oncology

Reem A. Assal
Hannah H. Rashwan
Zeina I. Zakaria
Jana H. Sweillam
Yasmine M. Fouda
Abdelhamid M. Abdelhamid
Rana A. Youness

Frontiers in Oncology

doi 10.3389/fonc.2025.1519103

368 views

Review

Published on 01 Apr 2025

LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies

in Molecular and Cellular Oncology

WeiChi Liu
WeiFa Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1552773

176 views

Systematic Review

Published on 31 Mar 2025

The rising influence of lipid metabolism in lung cancer: a global research perspective

in Molecular and Cellular Oncology

Chaoqun Wang
Ming Lei
Wei Wang
Yuanyuan Jiang
Jiefeng Zhang
Yi Zhang
Bin Zhao
Wenyang Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1562621

184 views

Review

Published on 31 Mar 2025

Liquid-liquid phase separation in cell physiology and cancer biology: recent advances and therapeutic implications

in Molecular and Cellular Oncology

Ziyuan Huang
Zimeng Liu
Lieqian Chen
Yanlin Liu
Gaofei Yan
Yizheng Ni
Qiuxia Yan
Wenqian He
Junhong Liu
Shufang Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1540427

240 views

Mini Review

Accepted on 27 Mar 2025

A review shows that ATG10 has been identified as a potential prognostic marker and therapeutic target for cancer patients based on real-world studies

in Molecular and Cellular Oncology

Ke Shi
Di Ke
Feng Li
Rong-Shu Shi
Tao Liu
Dan Li
Qun-Xian Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1573378

Review

Published on 27 Mar 2025

The NIMA-related kinase family and cancer

in Molecular and Cellular Oncology

Haotian Li
Junhan Li
Yue Zhang
Ran Cao
Congcong Guo
Mingwen Jiao

Frontiers in Oncology

doi 10.3389/fonc.2025.1556917

210 views

Original Research

Accepted on 26 Mar 2025

Examination of the Functions and Mechanism of KCP in Mediating Paclitaxel Resistance in Cervical Squamous Carcinoma Cells

in Molecular and Cellular Oncology

Yue He
Jian-Qing Xu
Jing-Jing Zhang
Zhen-You Liu
Chen Ji
Yang Liu
Yun-Fan Wang
Ming Wang
Yumei Wu
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1550032